AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise. The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).
Learn more about the comment process
AMIA responses are arranged by Federal Agency and Congressional Committee.
Looking back, historians may point to 2023 as the year humans collectively began to take notice of large-scale artificial intelligence (AI) potential impact on society. Researchers at Beth Israel Deaconess Medical Center (BIDMC) and colleagues across the country have been thinking about it for more than two decades.
In collaboration […]
It is 25x5’s stance that the below policy reforms are imperative to reducing onerous and redundant documentation burden, which is imperative to maintain the healthcare workforce and improve patient access to necessary medical care.
25x5 is a Task Force within the American Medical Informatics Association (AMIA) that works to reduce […]
It is 25x5’s position that prior authorization must be eliminated to reduce the required onerous documentation needed to support it, maintain the healthcare workforce, and improve patient access to necessary medical care. Prior authorization (PA) is a process used by health insurance companies, including Medicare Advantage (MA) plans, requiring clinicians […]
AMIA, along with 170 organizations, signed on in support of the Telehealth Expansion Act of 2023 and encouraging both chambers of Congress to pass the bill. Attached are each of the letters to House and Senate leadership.
AMIA appreciates ONC’s efforts to solicit feedback on the 2023 Interoperability Standards Advisory in preparation for the tenth annual reference edition. Overall, AMIA encourages ONC to ensure that all stakeholders are consulted to broaden the of range and address interoperability needs in Health IT. AMIA recognizes and values ONC’s thorough […]
Generally, AMIA encourages FTC to ensure that HBNR and HIPAA are aligned such that there are no gaps in regulation over the covered entities and other non-covered entities that work with PHR; to align definitions with other agencies, including the definition of PHR; and to provide clarity around whether a […]
We appreciate ONC taking into account our prior comments supporting enhanced harmonization of policies among agencies including the Food and Drug Administration (FDA), the Federal Trade Commission (FTC), and the Centers for Medicare and Medicaid Services (CMS). We also strongly support the use of updated vocabulary standards as found in […]
AMIA supports efforts by HHS to revise the Standards for Privacy of Individually Identifiable Health Information (“Privacy Rule”) under HIPAA and HITECH Act, to implement protections limiting uses and disclosures of protected health information (PHI) for certain purposes where the use or disclosure of information is about reproductive health care […]